๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Transplantation for cholangiocarcinoma

โœ Scribed by Debra L. Sudan


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
50 KB
Volume
12
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Transplantation for hilar cholangiocarci
โœ Julie K. Heimbach; Michael G. Haddock; Steven R. Alberts; Scott L. Nyberg; Micha ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 134 KB

## Key Points 1. Patients with primary sclerosing cholangitis (PSC) have a 8 to 12% risk of developing cholangiocarcinoma (CCA). 2. Cytologic techniques for aneuploidy such as digital image analysis and fluorescence in situ hybridization increase the detection rate for CCA. 3. Survival following re

Mixed hepatocellular cholangiocarcinoma
โœ Gonzalo Sapisochin; Nicholas Fidelman; John P. Roberts; Francis Y. Yao ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 426 KB

Mixed hepatocellular cholangiocarcinoma (HCC-CC) and intrahepatic cholangiocarcinoma (I-CC) are increasingly being reported in patients with cirrhosis. The aims of this study were (1) to evaluate the incidence, imaging features, and posttransplant outcomes for patients who underwent transplantation

Liver transplantation for incidental cho
โœ Peter Ghali; Paul J. Marotta; Eric M. Yoshida; Vincent G. Bain; Denis Marleau; K ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 97 KB

Cholangiocarcinoma is a biliary tumor, which not infrequently complicates primary sclerosing cholangitis. It carries a poor prognosis and, with the exception of carefully selected individuals in research protocols, contraindicates orthotopic liver transplantation. There has been some suggestion that

Vascular complications after orthotopic
โœ Hendrik T.J. Mantel; Charles B. Rosen; Julie K. Heimbach; Scott L. Nyberg; Micha ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 144 KB

Liver transplantation after neoadjuvant chemoradiotherapy has emerged as an effective treatment for patients with localized, node-negative, unresectable hilar cholangiocarcinoma (CCA) or CCA arising in the setting of primary sclerosing cholangitis (PSC). However, concern has arisen regarding the pot